Search
for
Sort by
Research 151–180 of 454
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial
- Treatment of androgenetic alopecia in transgender people receiving testosterone therapy with sublingual minoxidil: A randomized, double-blind, placebo-controlled clinical trial
- FEA-guided co-design of bubble microneedles: controlled tip separation for rapid transdermal and sublingual delivery
- FEA-guided co-design of bubble microneedles: controlled tip separation for rapid transdermal and sublingual delivery
- FEA-guided co-design of bubble microneedles: controlled tip separation for rapid transdermal and sublingual delivery
- Congenital Hypotrichosis with Hair and Dental Ectodermal Features Responsive to Sublingual Minoxidil
- Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations
- 61720 The effect of sublingual minoxidil on androgenetic alopecia in transgender individuals receiving testosterone for gender-affirmation: A 24-week single-centre double-blinded, randomized, placebo-controlled clinical trial
- Sublingual Minoxidil Increases Fibre Diameter in Male Androgenetic Alopecia. - A proxy for Reversal of Hair Follicle Miniaturization.
- Sublingual Minoxidil 5 mg versus Oral Minoxidil 5 mg for male androgenetic alopecia: A double‐blind randomized clinical trial
- Tolerance and Safety Profile of Sublingual Minoxidil in the Treatment of Androgenic Alopecia
- Tolerance and safety profile of sublingual minoxidil in the treatment of androgenic alopecia
- Regrowth of hair in congenital triangular alopecia induced by sublingual minoxidil
- Efficacy of topical nanoemulsion (NB-002) for the treatment of distal subungual onychomycosis: A randomized, double-blind, vehicle-controlled trial
- Onycholemmal horn: A distinctive subungual tumour
- Faculty Opinions recommendation of Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double-blind, placebo-controlled, phase 1B clinical trial.
- Supplementary data: Treatment of androgenetic alopecia with sublingual minoxidil in transgender people receiving testosterone
- Supplementary data: Treatment of androgenetic alopecia with sublingual minoxidil in transgender people receiving testosterone
- Supplementary data: Treatment of androgenetic alopecia with sublingual minoxidil in transgender people receiving testosterone
- Sox9 expression in canine epithelial skin tumors
- Surgical Management of Severe Cicatricial Ectropion Secondary to Pityriasis Rubra Pilaris.
- Dermatologic diseases and pregnancy
- Inflammatory and non-melanocytic tumoral pathology of the nail
- Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique
- A comparative study of Fractional co2 laser combined with topical methotrexate versus Fractional co2 laser combined with topical [Calcipotriol + Betamethasone] in the treatment of nail psoriasis
- Functional salivary gland regeneration by transplantation of a bioengineered organ germ
- Alopecias in humans: biology, pathomechanisms and emerging therapies
- Oral Nitroglycerin and Hair Transplant Surgery
- CLINICAL NUTRITION PROGRAM IMPROVES FATIGUE, ANXIETY, BRAIN FOG AND IMMUNO-HORMONAL AND GASTROINTESTINAL SYMPTOMS IN A 40 YEAR OLD FEMALE WITH SYSTEMIC ERYTHEMATOUS LUPUS